The first patient received a dose of the high-precision gene editor in a new clinical trial for Wilson disease. Researchers hope it’s a one-and-done fix.
The first patient received a dose of the high-precision gene editor in a new clinical trial for Wilson disease. Researchers hope it’s a one-and-done fix.